Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma
Alexandra Lahtinen, Kari Lavikka, Anni Virtanen, et al.
Cancer Cell (2023) Vol. 41, Iss. 6, pp. 1103-1117.e12
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones
Aleksandr Ianevski, Kristen Nader, Kyriaki Driva, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers
Eros Azzalini, Giorgio Stanta, Vincenzo Canzonieri, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15077-15077
Open Access | Times Cited: 16
Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer
Inga-Maria Launonen, Erdoğan Pekcan Erkan, Iga Niemiec, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Exploring the Potential of Natural Killer Cell-Based Immunotherapy in Targeting High-Grade Serous Ovarian Carcinomas
Kawaljit Kaur, Jashan Sanghu, Sanaz Memarzadeh, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 677-677
Open Access | Times Cited: 4
Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer
Inga-Maria Launonen, Iga Niemiec, María Mercedes Hincapié-Otero, et al.
Cancer Cell (2024) Vol. 42, Iss. 12, pp. 2045-2063.e10
Closed Access | Times Cited: 4
jellyfisher: Visualize Spatiotemporal Tumor Evolution with Jellyfish Plots
Kari Lavikka
(2025)
Closed Access
Blocking copper transporter protein-dependent drug efflux with albumin-encapsulated Pt(IV) for synergistically enhanced chemo-immunotherapy
Man Fang, Lei Cao, Zhao Zhang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
A noncanonical role of SAT1 enables anchorage independence and peritoneal metastasis in ovarian cancer
Cuimiao Zheng, Gang Niu, Hao Tan, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma
Sanaz Jamalzadeh, Jun Dai, Kari Lavikka, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Exploring evolutionary trajectories in ovarian cancer patients by longitudinal analysis of ctDNA
Oliver Kutz, Stephan Drukewitz, Alexander Krüger, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2024) Vol. 62, Iss. 10, pp. 2070-2081
Closed Access | Times Cited: 3
A multiplex single-cell RNA-Seq pharmacotranscriptomics pipeline for drug discovery
Alice Dini, Harlan Barker, Emilia Piki, et al.
Nature Chemical Biology (2024)
Open Access | Times Cited: 3
PIK3R1 fusion drives chemoresistance in ovarian cancer by activating ERK1/2 and inducing rod and ring-like structures
Heidi Rausio, Alejandra Cervera, Vanina D. Heuser, et al.
Neoplasia (2024) Vol. 51, pp. 100987-100987
Open Access | Times Cited: 2
ROR1-STAT3 signaling contributes to ovarian cancer intra-tumor heterogeneity
Emilia Piki, Alice Dini, Juuli Raivola, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 6
HRD related signature 3 predicts clinical outcome in advanced tubo-ovarian high-grade serous carcinoma
Heidi Koskela, Yilin Li, Titta Joutsiniemi, et al.
Gynecologic Oncology (2023) Vol. 180, pp. 91-98
Open Access | Times Cited: 5
Locus-specific LINE-1 expression in clinical ovarian cancer specimens at the single-cell level
Anna Perkiö, Barun Pradhan, Fatih Genc, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Exploration of organoids in ovarian cancer: From basic research to clinical translation
Siyu Li, Ningjing Lei, Mengyu Chen, et al.
Translational Oncology (2024) Vol. 50, pp. 102130-102130
Open Access | Times Cited: 1
H&E image analysis pipeline for quantifying morphological features
Valeria Ariotta, Oskari Lehtonen, S. Salloum, et al.
Journal of Pathology Informatics (2023) Vol. 14, pp. 100339-100339
Open Access | Times Cited: 3
Circulating tumor DNA-based copy-number profiles enable monitoring treatment effects during therapy in high-grade serous carcinoma
Mai Nguyen, Anna Rajavuori, Kaisa Huhtinen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115630-115630
Open Access | Times Cited: 2
Evolutionary mode and timing of dissemination of high-grade serous carcinomas
Anita Sveen, Bjarne Johannessen, Solveig M.K. Klokkerud, et al.
JCI Insight (2024)
Open Access
The DiffInvex evolutionary model for conditional somatic selection identifies chemotherapy resistance genes in 10,000 cancer genomes
Ahmed Ibrahim Samir Khalil, Fran Supek
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Joint inference of mutational signatures from indels and single-nucleotide substitutions reveals prognostic impact of homologous recombination deficiency in tumors
Fran Supek, Patricia Ferrer-Torres
Research Square (Research Square) (2024)
Open Access
Single-cell RNA sequencing reveals the change in cytotoxic NK/T cells, epithelial cells and myeloid cells of the tumor microenvironment of high-grade serous ovarian carcinoma
Lingnan Meng, Shujuan Sun
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Autophagy unrelated transcriptional mechanisms of hydroxychloroquine resistance revealed by integrated multi-omics of evolved cancer cells
Silvia G. Vaena, Martin J. Romeo, Mirna Mina-Abouda, et al.
Cell Cycle (2024), pp. 1-21
Open Access
Molecular and functional profiling of primary normal ovarian cells defines insights into cancer development and drug-responses
Emilia Piki, Alice Dini, Frida Rantanen, et al.
Deleted Journal (2024) Vol. 32, Iss. 4, pp. 200903-200903
Open Access
Patient-Representative Cell Line Models in a Heterogeneous Disease: Comparison of Signaling Transduction Pathway Activity Between Ovarian Cancer Cell Lines and Ovarian Cancer
Cynthia S. E. Hendrikse, Pauline M. M. Theelen, Wim Verhaegh, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4041-4041
Open Access
Page 1 - Next Page

Scroll to top